411 REFERENCE · Wikibooks
Radiation Oncology/Physics/Radiation Protection
Reference material by Wikibooks contributors. This retains its source identity and is not 411 news reporting.
Radiation Protection
Effective Dose
Dose equivalent
H = Absorbed dose (D) * WR * N
Accounts for different impact of different RT modalities on the same issue (e.g. high LET has higher biological impact than low LET)
WR, previously known as Q, is the quality factor
N is geometry factor
Unit in Sievert (Sv)
X-ray, Gamma-ray, electrons: 1
Neutrons <10 keV: 5
Neutrons 10 keV - 100 keV: 10
Neutrons >100 keV to 20 MeV:10
Neutrons >20 MeV:5
Protons >2 MeV: 2-5
Alpha, heavy nuclei: 20
Effective dose equivalent
Total effective dose to a given organ, across all types of radiation received by that organ. This may be useful in estimating the effective organ dose from nuclear explosion, etc.
HT: ΣR (D * WR)
Effective dose
Whole body effective dose, across multiple tissues and multiple types of radiation
E: ΣT (HT * WT)
Gonads: 0.20
Bone marrow, colon, stomach, lung: 0.12
Breast, bladder, esophagus, liver, thyroid: 0.05
Skin, brain, kidneys, salivary gland: 0.01
14 remaining tissues composite: 0.1
Committed dose: integral over 50 years of dose-equivalent
Sources of Exposure
Natural background (~3 mSv)
Radon: 2 mSv/year (56% total). EPA action level 148 Bq/m3 (4 pCi/l)
Internal: 0.4 mSv/year (11%)
Terrestrial nonradon: 0.3 mSv/year
Cosmic: 0.3 mSv/year
By location
USA Average: 0.8 mSv/year
Atlantic Coast: 0.3 mSv/year
Ramsar, Iran: 390 mSv/year
Cross-country U.S. flight: 0.05 mSv/flight
Man-made background
Diagnostic x-rays: 0.4 mSv/year (11%) - historical, may be as high as 3 mSv per year with CT scan use
Chest x-ray: 0.08 mSv/study
Dental x-ray: 0.1 mSv/study
Body CT: 11 mSv/study
Nuclear medicine studies: 0.1 mSv/year
Exposure Limits
Anual exposure limits (NCRP #91/116)
Occupational exposure
Radiation worker: 50 mSv/year (actual average dose received ~2 mSv)
Lens: 150 mSv/year
Individual organs (e.g. hands): 500 mSv/year
Emergency permissible dose: 0.5 Sv (=50 R)
Public exposure
Infrequent: 5 mSv/year
Continuous: 1 mSv/year
Lens: 15 mSv/year
Individual organs: 5 mSv/year
By Age: 10 mSv x years
Negligible individual dose: 0.01 mSv/year
Children
Child <18: 1 mSv/year
Embryo/fetus: 5 mSv/year
Embryo/fetus (after declared pregnancy): 0.5 mSv/month
Area limits
Controlled area: 1 mSv/week = 50 mSv/year
Uncontrolled area: 0.1 mSv/week = 5 mSv/year
Dose rate signs
Controlled area sign: >0.02 mSv/h
Radiation area sign: >0.05 mSv/h
Shipping
Transportation Index (TI) is dose rate at 1 m from surface of package
Container must be DOT approved
Radioactive source warning label must be on the container
Activity and radionuclide must be on the label
White label: No dose rate
Yellow II: Dose rate 0-0.01 mSv/h
Yellow III: Dose rate 0.01 - 0.1 mSv/h
Genetically significant dose (GSD)
Equivalent dose to gonads, weighted for age of exposed individuals, over entire population. It is the dose that, if received by every member of the population, would result in the same genetic injury to the entire population
Natural background: 0.25 mSv
Medical diagnostic: 0.2-0.3 mSv
Nuclear medicine: 0.02 mSv
Doubling dose
The doubling dose is estimated as a ratio of the average rates of spontaneous and induced mutations in a defined set of genes
Human spontaneous mutation rate ~3 x 10-6 per gene
Mouse induced mutation rate ~3 x 10-6 per gene per Gy
Resultant dose to double risk of mutation over spontaneous (doubling dose) ~1 Gy
Human data from Hiroshima/Nagasaki suggest somewhat higher average doubling dose of 1.6 Sv
Risk of radiation induced cancers
Dose and dose rate effectiveness factor (DDREF): Dose >0.2 Gy or dose rate >0.1 Gy/hr double rate of radiation carcinogenesis
Whole population fatal cancer: 5% / Sv (leukemia is 20% = 1% / Sv)
High dose or high dose rate risk: 10% / Sv
Working population fatal cancer: 4% / Sv (excludes children who have higher risk)
High dose or high dose rate risk: 8% / Sv
Hereditary disorders for reproductive population: 0.2% / Sv
Hereditary disorders for working population: 0.1% / Sv
Excess risk for population = Population (persons) * excess risk (risk per Sv) * exposure (Sv)
Risk of mental retardation during fetal exposure
Risk is 40% per 1 Sv
Largest risk is between 8-15 weeks; at 16-25 weeks, this risk is 4 times lower.
IQ drops 30 points per 1 Sv
Threshhold is no larger than 0.2 Gy
Internal Sources
Types of internal radiation
Locally absorbed: within 1 cm (typically beta and low energy characteristic)
Penetrating: >=1cm (internal gamma)
Maximum permissible body burden (MPBB) per 40 hour week
I-131: Thyroid 0.7 μCi
P-32: Bone 6.0 μCi
Effective half-life
Accounts for physical half-life and for biologic half-life, always less than either
teff,uptake = (tbiol, uptake * tphys) / (tbiol, uptake + tphys)
teff,elim = (tbiol, elim * tphys) / (tbiol, elim + tphys)
Contaminated articles must be stored until decay (usually 5 half-lives)
Patient cannot be released until dose rate at 1 m falls below
I-125: 0.01 mSv/h
Pd-103: 0.03 mSv/h
Ir-192: 0.008 mSv/h
I-131: 0.07 mSv/h
Total annual dose to individual members of public cannot exceed 1 mSv
Visitors to inpatients with radioactive material can visit if
Total dose <5 mSv
Authorized user approves visit
Medical Events (NRC 2002)
Dose differs from prescribed dose by
At least (and Relative below)
50 mSv effective dose
500 mSv organ dose
500 mSv skin
Relative (given At least above)
Total dose 20%
Fraction dose 50%
Wrong radioactive drug
Wrong route of administration
Wrong individual
Wrong mode of treatment
Leaked sealed source
Any event that will result in unintended permanent functional damage
NRC must be notified by phone by next calendar day
Written report must be submitted within 15 days
Referring physician must be notified
Patient shall be notified within 24 hours, unless referring physician feels that telling the patient would be harmful
Shielding
Barriers
Primary: attenuate direct beam
Secondary: attenuate scattered radiation and leakage radiation
Shielding equation: D = B * W * U * T / d2
Where D is dose
B is barrier transmission factor
W is workload: beam-on time, given in Gy at 1 m, usually 200-500 Gy/wk
U is use factor: fraction of time during which RT is striking the barrier; floory typically 1, walls typically 1/4, ceiling typically 1/2. With IMRT/Cyberknife, these numbers are higher
T is occupancy factor: fraction of time during which area behind barrier is occupied; work areas 1, corridors 1/4, stairways 1/8
d is distance: typically in meters from isocenter